Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Return on Equity: 2013-2025

Historic Return on Equity for Fortress Biotech (FBIO) over the last 12 years, with Sep 2025 value amounting to -1.38%.

  • Fortress Biotech's Return on Equity fell 1006.00% to -1.38% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.38%, marking a year-over-year decrease of 1006.00%. This contributed to the annual value of -5.34% for FY2024, which is 109.00% down from last year.
  • Per Fortress Biotech's latest filing, its Return on Equity stood at -1.38% for Q3 2025, which was up 52.46% from -2.90% recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Return on Equity peaked at 12.02% during Q3 2023, and registered a low of -112.72% during Q2 2023.
  • Moreover, its 3-year median value for Return on Equity was -3.69% (2025), whereas its average is -14.86%.
  • Per our database at Business Quant, Fortress Biotech's Return on Equity slumped by 11,149bps in 2023 and then skyrocketed by 12,380bps in 2024.
  • Fortress Biotech's Return on Equity (Quarterly) stood at -0.84% in 2021, then slumped by 191bps to -2.75% in 2022, then slumped by 2,884bps to -31.59% in 2023, then skyrocketed by 839bps to -23.21% in 2024, then slumped by 1,006bps to -1.38% in 2025.
  • Its Return on Equity was -1.38% in Q3 2025, compared to -2.90% in Q2 2025 and -3.69% in Q1 2025.